| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | EP0996719A4 A novel nucleic acid molecule |
| 05/08/2002 | CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348332A Vaccines and gene therapy compositions and methods of making and using the same |
| 05/08/2002 | CN1348005A Prepn and use of reconstituted target cysteine asparagusic enzyme gene |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6384018 For inducing immune responses in a vertebrate against mycobacterial epitopes |
| 05/07/2002 | US6383814 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 05/07/2002 | US6383809 Antisense inhibition of cytohesin-1 expression |
| 05/07/2002 | US6383808 Antisense inhibition of clusterin expression |
| 05/07/2002 | US6383807 Method of transforming T lymphocytes |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383760 Contacting receptor with test compound, then determining if compound binds to receptor |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
| 05/07/2002 | US6383733 Methods of screening for pharmacologically active compounds for the treatment of tumour diseases |
| 05/07/2002 | US6383512 For delivering to cell a composition comprising local anesthetic and nucleic acid molecules that comprise a nucleotide sequence that encodes an antisense oligonucleotide, a ribozyme, and a triplex forming nucleic acid |
| 05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
| 05/06/2002 | WO2002038178A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/06/2002 | CA2429404A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/03/2002 | WO2002035962A1 Hair clip |
| 05/03/2002 | CA2377219A1 Hair clip |
| 05/02/2002 | WO2002035240A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034920A2 Regulation of human ceruloplasmin-like protein |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034912A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034901A2 Protein kinase |
| 05/02/2002 | WO2002034892A1 Modified phage, comprising a non-lytic modification and expressing a kil-gene |
| 05/02/2002 | WO2002034879A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | WO2002034781A1 Human g-protein coupled diadenosine tetraphosphate receptor (ap4ar) |
| 05/02/2002 | WO2002034770A1 Identification of hla-dr restricted hcv epitopes |
| 05/02/2002 | WO2002034296A1 A novel gene therapy agent for haemophilia b and its preparation method |
| 05/02/2002 | WO2002034291A2 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
| 05/02/2002 | WO2002034201A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2001098361A3 Agonist anti-trk-c monoclonal antibodies |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001083710A3 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001070951A3 Agent for the diagnosis and therapy of viral diseases |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001066150A3 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 05/02/2002 | WO2001064741A3 Methods for selectively modulating survivin apoptosis pathways |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001055314A3 Digestive system related nucleic acids, proteins and antibodies |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001048209A3 Genes identified as required for proliferation of e. coli |
| 05/02/2002 | WO2001044287A3 Novel polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001040301A3 A gene, disrupted in schizophrenia |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001027292A3 Methods and compositions for targeting a cell |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001011068A3 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 05/02/2002 | WO2001002423A9 2'-guanidinyl-substituted oligonucleotides and gene expression modulation therewith |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078960A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020053092 Generation and recovering transgenic stem cells; obtain gonad, inject transfection mixture, insert expression vector into genome, recover transgenic stem cells |
| 05/02/2002 | US20020052478 Viricides to control virus replication and delay the onset of HIV-1-related disease symptoms; combined the protease cleavage site residues of the Gag/Gag-Pol precursor proteins and the virion-specific feature of Vpr; DNA construct |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052473 Polypeptide for use as diagnostic tool and in the treatment of sepsis, arthritis, graft versus host disease, and stroke; antiischemic agents |
| 05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 05/02/2002 | US20020052335 Complexing a polynucleotide and a polymer (e.g., polyimidazoles, polypyridines, polyaniline) to form a complex wherein the zeta potential of the complex is less negative than the polynucleotide alone at physiological pH |
| 05/02/2002 | US20020052333 Therapeutic use of cis-element decoys in vivo |
| 05/02/2002 | US20020052332 Methods of inhibiting retinal pigment epithelial cell degeneration, stable cell lines, and uses |
| 05/02/2002 | US20020052331 Of a capped target mRNA; oligonucleoides that inhibit protein translation directly via interference with ribosome assembly. |
| 05/02/2002 | US20020052330 Utilizing SBELEVTM polypeptides and polynucleotides in therapy, and diagnostic assays |
| 05/02/2002 | US20020052308 Nucleic acids, proteins and antibodies |
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052035 18891, a novel human lipase |
| 05/02/2002 | US20020052030 Nucleotide sequences coding preferential polypeptide for use in treatment of immune defects in animals; for use in veterinary medicine |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051966 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 05/02/2002 | US20020051767 Cancer treatment |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051762 Purified populations of endothelial progenitor cells |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |